A 360° View of the News.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Pope Francis
Social Media
Artificial Intelligence
Soccer
World Press Freedom Day
Motorsports
Home Run
Boxing
Vatican
World War II
Drones
Published • loading... • Updated

HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of ...

Summary by Enid News & Eagle
HONG KONG and FLORHAM PARK, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in gastric…

1 Articles

All
Left
1
Center
Right
Enid News & EagleEnid News & Eagle
Lean Left

HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of ...

HONG KONG and FLORHAM PARK, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in gastric…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news in on Tuesday, April 22, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Florham Park

Florham Park

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal